PREMENSTRUAL SYNDROME: DIAGNOSIS AND TREATMENT


A.L. Unanyan (1), S.E. Arakelov (2), L.S. Polonskaya (2), T.D. Guriev (1), V.D. Morozova (3)

(1) Department of Obstetrics and Gynecology №1, SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH, Moscow; (2) City Clinical Hospital № 53, Moscow; (3) Department of Psychiatry and Narcology SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH, Moscow
The article discusses the modern concept of the complex pathogenesis of premenstrual syndrome (PMS) and approaches to its treatment. The diversity of clinical manifestations of PMS that causes a variety of therapeutic agents used is emphasized. Numerous studies suggests the great importance of magnesium deficiency as a factor of the development of PMS. This indicates the necessity of magnesium preparations (in particular, magnesium orotate) for all types of treatment of PMS.

About the Autors


A.L. Unanyan – MD, Prof. at the Department of Obstetrics and Gynecology №1, SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH; e-mail: 9603526@mail.ru
S.E. Arakelov – PhD in Medical Sciences, Chief Physician of the CCH № 53, Moscow, Assistant Professor at the Department of Obstetrics and Gynecology of the Russian People’s Friendship University; e-mail: 53mosgkb@gmail.com
L.S. Polonskaya - PhD in Medical Sciences, Head of the gynecological department CCH № 53; e-mail: ml.7951447@gmail.com
T.D. Guriev – MD, Prof. at the Department of Obstetrics and Gynecology, SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH; e-mail: 9603526@mail.ru
V.D. Morozova - PhD in Medical Sciences, Associate Professor at the Department of Psychiatry and Narcology SBEI HPE "First MSMU n.a. I.M. Sechenov" of RMPH; e-mail: 9603526@mail.ru


Similar Articles


Бионика Медиа